MedPath

Behavioral Interventions to Target Self-Control

Not Applicable
Completed
Conditions
Tobacco Smoking
Registration Number
NCT02281942
Lead Sponsor
Oregon Health and Science University
Brief Summary

Low self-control has been associated with a number of unhealthy behaviors with low treatment success. Alternative non-pharmacological approaches have the potential for enhancing self-control. This pilot study will investigate if the practice of yoga and/or health and wellness education improve self-control in the context of nicotine addiction, and will set the stage for larger clinical trials using behavioral interventions to supplement or replace existing treatments and increase the rates of recovery from disorders in which low self-control is a susceptibility factor.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
39
Inclusion Criteria
  • should smoke a minimum of 10 cigarettes/day
  • be fluent speaking and reading English
  • in good physical health
  • intend to quit smoking
  • capable of abstaining from smoking for 12-14 hours
  • should have easy daily access to a computer and/or other internet-enabled device
Exclusion Criteria
  • current alcohol or substance use disorder (except nicotine)
  • pregnancy
  • history of psychosis or bipolar disorder
  • current use of a behavioral or pharmacologic tobacco treatment
  • any untreated medical or psychiatric condition that might compromise their safety during participation in the study (e.g. high blood pressure, diabetes, BMI >35)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Time (minutes) to first smoke after 12-hour abstinenceAssessed 1 week after visit 1 during a 2-hour abstinence reinforcement session
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Oregon Health & Science University

🇺🇸

Portland, Oregon, United States

Oregon Health & Science University
🇺🇸Portland, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.